Cite

HARVARD Citation

    Sibartie, M. et al. (2021). Evolocumab use and LDL-C lowering in a cohort of European patients with familial hypercholesterolemia (FH) - results from the Heymans study. Atherosclerosis. pp. e21-. [Online]. 
  
Back to record